Mentype® DigitalScreen / DigitalQuant assays are available for the digital PCR-based chimerism analysis. Mentype® DigitalScreen mediates the donor/recipient screening for informative loci. Allele-specific Mentype® DigitalQuant duplex-assays allow highly sensitive and accurate chimerism monitoring. Digital PCR (dPCR) is a quantitative approach to assess the absolute copy number of target DNA. It is easy to perform, needs only small amounts of DNA and does not require the use of standard curves and replicate analysis. Particularly in the difficult range of mixed chimerism dPCR-based Mentype® DigitalScreen / DigitalQuant are perfectly suited

Learn more

 

ChimerisTM Monitor 2.0 – the new professional software for automated chimerism analysis combining speed and accuracy with an intuitive and customised interface.

•  Calculation of percent-chimerism
•  High resolution reports
•  Selection of informative loci through color coding
•  Parallel comparison of chimerism in diverse specimens
•  Direct fsa-file import
•  No need for additional fragment length analysis software

Learn more

 

Mentype® DIPquant the quantitative approach
for allele-specific monitoring

Mentype® DIPscreen mediats the switch towards quantitative analysis

Mentype® Chimera® the established standard for chimerism testing in early stages of transplant engraftment

ChimerisTM Monitor 2.0 the encompassing
software for analysis and quantification

With the combination of multiplex PCR and Lateral-Flow analysis, the Biotype Diagnostic GmbH offers unrivaled an extremely sensitive and rapid detection of pathogens of dermatomycosis according to the requirements of the the MiQ* and the new Rili-BÄK** guidelines.

Mentype® MycoDermQS Lateral Flow

•  Detection of all pathogen classes dermatophytes, yeasts, molds and 12 species within
•  Certain identification of mixed  infections
•  Diagnosis of already medicated or treated patients
•  Lab investigation is completed within 24 hours
•  MiQ and Rili-BÄK conformity

Learn more

 

14-03-2017
New dynamics in monitoring diagnostics in leukemia
The new assays DigitalScreen/DigitalQuant of the Biotype Diagnostic GmbH ensure a robust and highly sensitive evaluation of disease progression after stem cell transplantation based on the innovative digital PCR technology.

Read more

 

Please feel free to get in contact with our experts at congresses, conferences, workshops and symposia.

Learn more